Overview

Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study is designed to improve knowledge regarding the initial effectiveness of N-acetylcysteine (NAC) on cold and cough symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis
Treatments:
Acetylcysteine
N-monoacetylcystine